Article 05 Apr 2025 Texas Court Vacates FDA's Laboratory Developed Test (LDT) Final Rule United States Healthcare
Article 19 Mar 2025 Compounded GLP-1 Drugs: Texas Judge Denies PI Motion And Request For Stay Of FDA's Declaration That Tirzepatide Shortage Is Resolved; Plaintiff OFA Appeals United States Healthcare
Article 09 Jan 2025 AI-Enabled Device Software Functions: FDA's Final Guidance For Predetermined Change Control Plans United States Technology
Article 02 Jan 2025 GLP-1 Drugs: FDA "Re-Confirms" Decision Removing Tirzepatide From The Drug Shortage List United States Healthcare
Article 17 Dec 2024 Antibody Drug Conjugates Keep Growing: What You Need To Know United States Healthcare
Article 03 Dec 2024 GLP-1 Drugs: Brand Companies Push FDA To Limit Compounding United States Healthcare
Article 25 Oct 2024 GLP-1 Drugs: FDA Sued Over Removing Tirzepatide From The Drug Shortage List United States Healthcare
Article 09 Oct 2024 GLP-1 Drugs: FDA Removes Lilly's Zepbound® And Mounjaro® (Tirzepatide Injection) From Its Drug Shortage List United States Healthcare